Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Forte Biosciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 31 | 31 | 0 |
| Shares | 3.47M | 16.7M | +13.2M (+381.9%) |
| Value | $3.60M | $11.1M | +$7.45M (+206.9%) |
New holders (8)
Institutions that held Forte Biosciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tybourne Capital Management (HK) Ltd | 3,624,548 | $2.40M | 0.34% |
| Perceptive Advisors LLC | 3,265,359 | $2.16M | 0.07% |
| BVF Inc | 2,982,105 | $1.97M | 0.05% |
| Fred Alger Management, LLC | 1,838,965 | $1.22M | 0.01% |
| Farallon Capital Management, L.L.C. | 1,810,455 | $1.20M | 0.01% |
| Jane Street Group, LLC | 10,763 | $7.13K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,181 | $2.11K | 0.00% |
| Qube Research & Technologies Ltd | 3 | $2 | 0.00% |
Sold out (8)
Institutions that held Forte Biosciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Old Well Partners, LLC | 68,600 | $71.3K |
| Millennium Management LLC | 57,102 | $59.4K |
| Bridgeway Capital Management, LLC | 36,865 | $38.3K |
| Susquehanna International Group, LLP | 30,319 | $31.5K |
| Citadel Advisors LLC | 22,505 | $23.4K |
| FNY Investment Advisers, LLC | 9,564 | $9.00K |
| Simplex Trading, LLC | 1,346 | $1.00K |
| Royal Bank of Canada | 155 | $0 |